Risk factors associated with hemorrhagic complications
| Odds Ratio | 95% Wald CI | P Value | |
|---|---|---|---|
| Sex | 0.640 | 0.205–1.994 | .441 |
| Age | 1.013 | 0.965–1.063 | .613 |
| Hypertension | 0.549 | 0.179–1.679 | .293 |
| Smoking | 1.138 | 0.385–3.363 | .814 |
| Previous stroke/TIA | 0.600 | 0.129–2.796 | .516 |
| Dyslipidemia | 0.800 | 0.233–2.744 | .722 |
| Prior antithrombotic usage | 0.978 | 0.244–3.928 | .975 |
| Aneurysm presentation | |||
| Unruptured, symptomatic | 0.380 | 0.039–3.726 | .406 |
| Recurrent or residual | 1.187 | 0.345–4.081 | .786 |
| Aneurysm location (posterior circulation) | 1.755 | 0.525–5.864 | .361 |
| Aneurysm morphology (fusiform) | 0.592 | 0.060–5.840 | .654 |
| Aneurysm size | 0.989 | 0.904–1.083 | .812 |
| Antiplatelet medication (ticagrelor) | 0.669 | 0.230–1.946 | .461 |
| Treatment technique (flow-diverter) | 0.948 | 0.297–3.025 | .929 |